Biotech MavenHot Analyst Reads4 Hot Analyst Reads For Friday, July 20thBiotech MavenJul 20, 2018Repligen price target raised to $56 from $45 at Citi RGEN - The FlyRepligen price target raised to $56 from $45 at Citi Citi RGENthefly.com
